DXB 1.64% 30.0¢ dimerix limited

Ann: Change of Director's Interest Notice x 2, page-105

  1. 1,174 Posts.
    lightbulb Created with Sketch. 119
    Majority of shareholders wouldn't and the BoD should be trying to maximise SH value. Maybe that's why talks are ongoing I.e not already happened Given today is abit slower than normal, anyone care to take a punt on what a minimum deal would be...having the ph2a data? E.g. guessing 5 million (trials) + 2 million (Corp) for 2b So incl ph3... 20 / 30 million Round to 40 million to finish ph3. What would Big pharma get % if sales over x years? Cheers Any comparable examples with companies at a similar stage?
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.005(1.64%)
Mkt cap ! $164.5M
Open High Low Value Volume
31.0¢ 31.0¢ 30.0¢ $818.6K 2.683M

Buyers (Bids)

No. Vol. Price($)
15 1874183 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 10850 1
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
30.0¢
  Change
-0.005 ( 1.64 %)
Open High Low Volume
31.0¢ 31.0¢ 30.0¢ 640607
Last updated 15.54pm 28/03/2024 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.